| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A combination of ifosfamide and mitoxantrone as salvage therapy in patients with advanced ovarian cancer
|
Nardi, M.
|
|
1996
|
38 |
3 |
p. 298-301
|
artikel
|
| 2 |
Antitumor mechanism of action of a cyclopropyl antiestrogen (compound 7b) on human breast cancer cells in culture
|
Jain, P. T.
|
|
1996
|
38 |
3 |
p. 238-244
|
artikel
|
| 3 |
Antitumour evaluation of dolastatins 10 and 15 and their measurement in plasma by radioimmunoassay
|
Aherne, G. W.
|
|
1996
|
38 |
3 |
p. 225-232
|
artikel
|
| 4 |
A phase II study of CI-973 [SP-4-3(R)]- [1, 1-cyclobutane-dicarboxylato (2-)] (2-methyl-1,4-butanediamine-N, N′) platinum in patients with refractory advanced breast cancer
|
Theriault, R. L.
|
|
1996
|
38 |
3 |
p. 289-291
|
artikel
|
| 5 |
Biochemical modulation of fluorouracil: comparison of methotrexate, folinic acid, and fluorouracil versus folinic acid and fluorouracil in advanced colorectal cancer: a randomized trial
|
Polyzos, A.
|
|
1996
|
38 |
3 |
p. 292-297
|
artikel
|
| 6 |
Differential single- versus double-strand DNA breakage produced by doxorubicin and its morpholinyl analogues
|
Duran, George E.
|
|
1996
|
38 |
3 |
p. 210-216
|
artikel
|
| 7 |
Differentiation of HL-60 cells distinguishes between cytostatic and cytotoxic effects of the alkylphospholipid ET-18-OCH3
|
Civoli, F.
|
|
1996
|
38 |
3 |
p. 269-272
|
artikel
|
| 8 |
Exogenous hepatocyte growth factor markedly stimulates liver regeneration following portal branch ligation in dogs
|
Ueno, Shinichi
|
|
1996
|
38 |
3 |
p. 233-237
|
artikel
|
| 9 |
Functional aspects of membrane folate receptors in human breast cancer cells with transport-related resistance to methotrexate
|
Pinard, Marie-France
|
|
1996
|
38 |
3 |
p. 281-288
|
artikel
|
| 10 |
ICRF-187 rescue in etoposide treatment in vivo. A model targeting high-dose topoisomerase II poisons to CNS tumors
|
Holm, B.
|
|
1996
|
38 |
3 |
p. 203-209
|
artikel
|
| 11 |
Nucleotide excision repair in the human ovarian carcinoma cell line (2008) and its cisplatin-resistant variant (C13*)
|
Moorehead, Roger A.
|
|
1996
|
38 |
3 |
p. 245-253
|
artikel
|
| 12 |
Pharmacokinetics and pharmacodynamics of the new podophyllotoxin derivative NK 611A study by the AIO groups PHASE-I and APOH
|
Mross, K.
|
|
1996
|
38 |
3 |
p. 217-224
|
artikel
|
| 13 |
Pharmacokinetics and pharmacodynamics of topotecan given on a daily-times-five schedule in phase II clinical trials using a limited-sampling procedure
|
van Warmerdam, L. J. C.
|
|
1996
|
38 |
3 |
p. 254-260
|
artikel
|
| 14 |
The effect of 9-β-D-arabinofuranosyl-2-fluoroadenine and 1-β-D-arabinofuranosylcytosine on the cell cycle phase distribution, topoisomerase II level, mitoxantrone cytotoxicity, and DNA strand break production in K562 human leukemia cells
|
Loughlin, Susan
|
|
1996
|
38 |
3 |
p. 261-268
|
artikel
|
| 15 |
The formation and persistence of carboplatin-DNA adducts in rats
|
Blommaert, Frank A.
|
|
1996
|
38 |
3 |
p. 273-280
|
artikel
|
Tijdschrift beschrijving